| 1 |
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
Sonja Ständer, Gil Yosipovitch, Franz Josef Legat et al. · New England Journal of Medicine
Open access |
19 Feb 2020 |
281 |
| 2 |
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka et al. · Journal of Allergy and Clinical Immunology
Open access |
23 Aug 2019 |
275 |
| 3 |
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Shawn G. Kwatra et al. · New England Journal of Medicine
Open access |
25 Oct 2023 |
189 |
| 4 |
Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
Satoshi Nakamizo et al. · The Journal of Experimental Medicine
Open access |
16 Jun 2021 |
172 |
| 5 |
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
Jonathan I. Silverberg et al. · The Lancet
|
24 Jul 2024 |
156 |
| 6 |
Interleukin-31 Signaling Bridges the Gap Between Immune Cells, the Nervous System and Epithelial Tissues
Jana Nemmer, Marcus Kuchner, Angeliki Datsi et al. · Frontiers in Medicine
Open access |
10 Feb 2021 |
100 |
| 7 |
Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab
Lam C. Tsoi, Fériel Hacini‐Rachinel, Paul Fogel et al. · Journal of Allergy and Clinical Immunology
Open access |
29 Nov 2021 |
96 |
| 8 |
Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
Kyle Allen Williams, Youkyung Sophie Roh, Isabelle D. Brown et al. · Expert Review of Clinical Pharmacology
|
16 Nov 2020 |
83 |
| 9 |
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey
Jerry K.L. Tan, Stefan Beissert, Fran E. Cook-Bolden et al. · American Journal of Clinical Dermatology
Open access |
27 Oct 2021 |
73 |
| 10 |
Health-related quality of life and economic burden of prurigo nodularis
Katherine A. Whang, Thomas K. Le, Raveena Khanna et al. · Journal of the American Academy of Dermatology
|
28 May 2021 |
73 |
| 11 |
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea
Martin Schaller, Lajos V. Kemény, Blanka Havlíčková et al. · Journal of the American Academy of Dermatology
Open access |
29 May 2019 |
70 |
| 12 |
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review
Joachim W. Fluhr, David J. Moore, Majella E. Lane et al. · Journal of the European Academy of Dermatology and Venereology
ReviewOpen access |
22 Dec 2023 |
69 |
| 13 |
What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study*
Jonathan I. Silverberg, Donald K. Lei, Muhammad Ali Yousaf et al. · British Journal of Dermatology
Open access |
5 Aug 2020 |
69 |
| 14 |
Clinical characteristics and disease burden in prurigo nodularis
Prachi Aggarwal, Justin J. Choi, Nishadh H. Sutaria et al. · Clinical and Experimental Dermatology
|
10 May 2021 |
67 |
| 15 |
Ultraviolet light protection by a sunscreen prevents interferon‐driven skin inflammation in cutaneous lupus erythematosus
Sabine Zahn, Medina Graef, Nikolaos Patsinakidis et al. · Experimental Dermatology
|
23 Apr 2014 |
66 |
| 16 |
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Sonja Ständer et al. · JAMA Dermatology
Open access101 authors |
27 Nov 2024 |
61 |
| 17 |
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study
Jonathan I. Silverberg, Andreas Pinter, Afsáneh Alavi et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
12 Mar 2021 |
59 |
| 18 |
Single-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab
Feiyang Ma, Mehrnaz Gharaee‐Kermani, Lam C. Tsoi et al. · Journal of Allergy and Clinical Immunology
Open access |
27 Jul 2023 |
55 |
| 19 |
Impact of facial and truncal acne on quality of life: A multi-country population-based survey
Jerry K.L. Tan, Stefan Beissert, Fran E. Cook-Bolden et al. · JAAD International
Open access |
27 Apr 2021 |
51 |
| 20 |
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances
Sonja Ständer, Gil Yosipovitch, J.‐P. Lacour et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
29 Jun 2022 |
50 |
| 21 |
Comparing skin characteristics and molecular markers of xerotic foot skin between diabetic and non-diabetic subjects: An exploratory study
Anna Lechner, Merve Akdeniz, Tsenka Tomova‐Simitchieva et al. · Journal of Tissue Viability
|
25 Sep 2019 |
49 |
| 22 |
Clinical phenotyping of atopic dermatitis using combined itch and lesional severity
Raj Chovatiya, Donald K. Lei, Adnan Ahmed et al. · Annals of Allergy Asthma & Immunology
|
2 Apr 2021 |
46 |
| 23 |
Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study
Jerry K.L. Tan, Stefan Beissert, Fran E. Cook-Bolden et al. · JAAD International
Open access |
23 Dec 2021 |
45 |
| 24 |
Association of atopic dermatitis severity with cognitive function in adults
Jonathan I. Silverberg, Donald K. Lei, Muhammad Ali Yousaf et al. · Journal of the American Academy of Dermatology
|
16 May 2020 |
45 |
| 25 |
Epidemiology of prurigo nodularis in England: a retrospective database analysis
Christopher Ll. Morgan, Melissa J. Thomas, Sonja Ständer et al. · British Journal of Dermatology
Open access |
27 Jan 2022 |
43 |
| 26 |
Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis*
Jorge Puelles, Fatoumata Fofana, Danielle N. Rodriguez et al. · British Journal of Dermatology
Open access |
6 Oct 2021 |
40 |
| 27 |
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents
Robert Sidbury, Sady Alpizar, Vivian T. Laquer et al. · Dermatology and Therapy
Open access |
28 Jan 2022 |
38 |
| 28 |
Association of itch triggers with atopic dermatitis severity and course in adults
Jonathan I. Silverberg, Donald K. Lei, Muhammad Ali Yousaf et al. · Annals of Allergy Asthma & Immunology
|
13 Jun 2020 |
36 |
| 29 |
Long-Term Effectiveness and Safety of Up to 48 Weeks’ Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne
Brigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley et al. · American Journal of Clinical Dermatology
|
17 Jun 2019 |
34 |
| 30 |
Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia
István Bitter, Jeffrey Alan Lieberman, Florence Gaudoux et al. · Neuropsychopharmacology
Open access |
Mar 2019 |
34 |
| 31 |
Correlation between Protoporphyrin IX Fluorescence Intensity, Photobleaching, Pain and Clinical Outcome of Actinic Keratosis Treated by Photodynamic Therapy
Filippo Piffaretti, Matthieu Zellweger, Behrooz Kasraee et al. · Dermatology
Open access |
2013 |
34 |
| 32 |
Content validity of a sleep numerical rating scale and a sleep diary in adults and adolescents with moderate-to-severe atopic dermatitis
Carla Dias-Barbosa, Rodolfo Matos, Margaret Vernon et al. · Journal of Patient-Reported Outcomes
Open access |
23 Nov 2020 |
33 |
| 33 |
Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
Stephen Matthew Schleicher, Angela Yen Moore, Elyse S. Rafal et al. · Dermatology and Therapy
Open access |
15 Oct 2023 |
30 |
| 34 |
Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis
Jonathan I. Silverberg, Donald K. Lei, Muhammad Ali Yousaf et al. · Annals of Allergy Asthma & Immunology
|
18 Mar 2020 |
29 |
| 35 |
Introducing Diffusing Wave Spectroscopy as a Process Analytical Tool for Pharmaceutical Emulsion Manufacturing
Mathias Reufer, Alexandra H.E. Machado, Andreas Niederquell et al. · Journal of Pharmaceutical Sciences
|
9 Oct 2014 |
29 |
| 36 |
Management of Acne Vulgaris With Trifarotene
Jerry K.L. Tan, Rajeev Chavda, Hilary E. Baldwin et al. · Journal of Cutaneous Medicine and Surgery
Open access |
16 Mar 2023 |
28 |
| 37 |
Longitudinal course and predictors of depressive symptoms in atopic dermatitis
Sheena Chatrath, Donald K. Lei, Muhammad Ali Yousaf et al. · Journal of the American Academy of Dermatology
|
9 May 2022 |
28 |
| 38 |
A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice
Mindy R. Hong, Donald K. Lei, Muhammad Ali Yousaf et al. · Annals of Allergy Asthma & Immunology
|
16 Jul 2020 |
26 |
| 39 |
Correlations between photoactivable porphyrins’ fluorescence, erythema and the pain induced by PDT on normal skin using ALA-derivatives
Jérôme Barge, Thomas M. Glanzmann, Matthieu Zellweger et al. · Photodiagnosis and Photodynamic Therapy
Open access |
12 Sep 2013 |
26 |
| 40 |
Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab
Junwen Deng, Viviane Liao, Varsha Parthasarathy et al. · JAMA Dermatology
Open access |
9 Aug 2023 |
25 |
| 41 |
Importance of treating acne sequelae in skin of color: 6‐month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne‐induced post‐inflammatory hyperpigmentation
Andrew F Alexis, JAMES Q. Del Rosso, Seth B. Forman et al. · International Journal of Dermatology
Open access |
29 Apr 2024 |
24 |
| 42 |
Patient Perspectives on Living With Severe Prurigo Nodularis
Danielle N. Rodriguez, Shawn G. Kwatra, Carla Dias-Barbosa et al. · JAMA Dermatology
Open access |
20 Sep 2023 |
24 |
| 43 |
Prevalence of prurigo nodularis in the United States
Katherine A. Whang, Varun Mahadevan, Pegah R. Bakhshi et al. · The Journal of Allergy and Clinical Immunology In Practice
|
9 Jun 2020 |
24 |
| 44 |
A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea‐prone skin
Hilary E. Baldwin, Francine Santoro, Nadège Lachmann et al. · Journal of Cosmetic Dermatology
Open access |
25 Feb 2019 |
22 |
| 45 |
Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients
Donald K. Lei, Muhammad Ali Yousaf, Sherief R. Janmohamed et al. · Annals of Allergy Asthma & Immunology
|
9 Dec 2019 |
21 |
| 46 |
Transcriptomics Analysis Indicates Trifarotene Reverses Acne-Related Gene Expression Changes
Brigitte Dréno, Rajeev Chavda, Valérie Julia et al. · Frontiers in Medicine
Open access |
22 Oct 2021 |
20 |
| 47 |
Measurement properties of the product of investigator’s global assessment and body surface area in children and adults with atopic dermatitis
Jonathan I. Silverberg, Donald K. Lei, Muhammad Ali Yousaf et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
3 Aug 2020 |
20 |
| 48 |
Comorbidities, healthcare resource utilization & treatment pattern among patients with prurigo nodularis, compared to a benchmark in Germany: A real‐world evidence claims data study
Sonja Ständer, Miriam Ketz, Divine Akumo et al. · Journal of the European Academy of Dermatology and Venereology
Open access |
11 Dec 2023 |
19 |
| 49 |
A Review of MAL-PDT for the Treatment Strategy of Actinic Keratosis: Broader Clinical Perspectives Beyond the Data and Guideline Recommendations
Rolf‐Markus Szeimies, Thomas Dirschka, Maria Concetta Fargnoli et al. · Dermatology and Therapy
Open access |
10 Jun 2023 |
18 |
| 50 |
Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients with Atopic Dermatitis
Jonathan I. Silverberg, Brad Lee, Donald K. Lei et al. · Dermatitis
|
3 Dec 2020 |
18 |